Abststract. Human African trypanosomiasis is often associated with an intense proliferation of B lymphocytes, leading to polyclonal antibody synthesis. Using a modified enzyme-linked immunosorbent assay method, we have found highly significant levels of circulating anti-conjugated tryptophan-like epitope antibodies in sera of patients with sleeping sickness. These antibodies were immunoglobulins (Ig) of the M isotype. There was no correlation between immunologic binding and the Ig levels found in sera of patients with human African trypanosomiasis. Higher antibody levels in stage II of the disease than in stage I may be related to damage to the central nervous system. The specificity of this immunologic binding was evaluated by 1) comparison with that obtained with other related conjugates and 2) serum titration. Anti-conjugated tryptophan-like epitope antibodies were not found in other neurologic diseases tested. Their involvement in this pathology remains unknown.
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The pathology of human African trypanosomiasis or sleeping sickness usually comprises two stages: stage I, during which there is no evidence of central nervous system (CNS) disturbances, and stage II, defined by the presence of parasites in the CNS. Many investigators have described a dysfunction and a dysregulation of the immune system in this disease.' A classic immunologic feature of human African trypanosomiasis is the production of large amounts of immunoglobulins (Ig), reflecting a nonspecific polyclonal B lymphocyte activationZ and a production of autoantibodies directed against antigens unrelated to those of the infecting parasite. Circulating autoantibodies directed against hippocampus and hypothalamus neurons have been reported in sera of infected rats.3 Autoantibodies to the myelin structure have been describedPb An increase in autoantibody titers may be due to tissue antigen release as a result of damage to the CNS by the parasite itself or inflammatory reactions, or to a large stimulation of the immune s y~t e m .~ Schultzberg and others reported that in the CNS, the trypanosomes are located in areas that have a poorly developed blood-brain barrier, i.e., the area postrema, pineal gland, and median eminence, which are periventricular organ.^ These investigators suggested that this distribution may be related to clinical symptoms. The parasites are also found in the ependymal cells of the choroid plexus and those of the ventricular c~a t .~,~ In these areas, the trypanosomes destroy the ependyma cells and the supraependyma plexus. A retrograde degeneration of serotoninergic neurons has also been noted.lo These serotoninergic pathways are implicated in slow-wave sleep genesis. The disturbances in the serotoninergic pathways could be due to T and B autoreactive cells, such as in other autoimmune mechanisms directed against endogenous, conjugated, small-sized molecules as previously described. I1-l3 In the present study, we investigated the levels of circulating autoantibodies directed against neurotransmitters of serotoninergic pathways and various related molecules and found circulating antibodies directed against tryptophan-like epitopes of the M isotype in sera of patients with human African trypanosomiasis.
MATERIALS AND METHODS
Human sera. Sera from 76 patients with trypanosomiasis (between 3 and 78 years of age) and 22 uninfected subjects (between 3 and 68 years of age) living in Bok0 Songho (Bouenza focus of the Congo) were studied. Clinical examination, parasite detection, and serologic analysis were performed.
Detection of trypaizosomes. This was performed in blood and lymph node fluid and, when required, in cerebrospinal fluid (CSF) by direct microscopic examination andlor using minicolumns of D E B cell~lose.'~ Serologic aitalysis. Antibodies directed against trypanosoma1 antigens were assayed in sera using an agglutination test and an indirect immunofluorescent testi5
The patients were divided in two groups: group I (early blood lymphatic stage) and group II (late meningoencephalitis stage) according to the presence of parasites and number of cells (early stage 5 4 cellslmm3 in the CSF and late stage > 4 cells/mm3). In the CSF of patients, the cells in question were lymphocytes and, in advanced late stages, plasma cells.
Sera of control groups were obtained from 10 Europeans (mean age = 28 years), 12 Africans who lived in France for more than two years (mean age = 10 years), and 12 Bolivians with Chagas' disease (mean age = 25 years).
Sera from 24 patients infected with human immunodeficiency virus-] (HIV-1) (supplied by the Department of Infectious Diseases, Hopital Pellegrin, Bordeaux, France), classified according to the Centers for Disease Control and Prevention (CDC) (Atlanta, GA)16 and divided into 14 HIVpositive patients and 10 patients with acquired immunodeficiency syndrome (AIDS), and sera from 12 patients with severe neurologic signs of Parkinson's disease (supplied by the Department of Neurology, Hopital Pellegrin) were also used. All of the latter patients presented with tremors, akinesia, and rigidity and were considered as being in the advanced stages of Parkinson's disease.
Conjugate synthesis. Six indoleainine molecules, tryptophan (W), 5-hydroxytrytophan (HW), 5methoxytry~to-phan (MW), tryptamine (T), 5-hydroxytryptamine (HT), *and ORSTOM Fonds Documentaire This solution was then frozen and dried. Activation of the carboxylic group was initiated by the rapid addition of 800 pl of anhydrous dimethylformamide Merck. Darmstadt. Germany) solution containing ethylchloroformate (Fluka) diluted 1/16. The mixture u'as incubated for 5 min at 4°C. A protein solution containing 20 mg of BSA in 2 ml of distilled water, and 40 (*.I of triethylamine (hlerck) was added. The conjugates were purified by dialysis against distilled water for 24 hr at 4°C. After dialysis, absorbances at 280 and 300 nm were measured for the determination of the molar coupling ratios, which ranged between 10 and 15. Determination of the amounts of immunoglobulins in human sera. Amounts of IgG. TgA, and Igh4 were evaluated using an imniunonephelometric method with a BNA nephelometer (Berhing, Marburg, Germany) in sera of patients with human African trypanosomiasis (n = 40) and controls (Africans from an endemic area: n = 22, healthy European blood donors: n = 10, Africans living in France: n = 12, and subjects with Chagas' disease: n = 12).
Enzyme-linked immunosorbent assay (ELISA ). A previously described ELISA method was adapted for our purp o s e~.~~ Polystyrene well plates (Nunc. Roskiltie, Denmark) \vere coated \vitIl 100 FI of : i solution containing either an indoleamine or catecholamine cori-jugate or glutaraldehydetreated ßSA (BSA-G) (or anhydric gluttiric acid-trcated BSA [SSA-AC] ) at a concentration of 10 pg/nil (opti~tium concentl.ation) in 0.05 hl cnlhoriats buffer pH 9.6. for I6 hr at 4°C. After this incubation, the \vel1 plates \ v t w tillcd v, i t h phu~plinte-hut'fered saline 1 PBS) coiitaining O.OSri. Tween 20 tPB.Z;-T\\wxl). 10% gl>cecrl~I. ; i t i d ßSA ( 5 g/L). 1'1.1~. \\ell plates \sere incubated ~L M -1 tir at 37'C to s;i[ur:itr them a n d pre\etit the nonsprcitic hinding i i f the Ig. The \vcll p h t e k were then rinsed tuice wilh I'RS-I\\ern to reii~ove tlic escess nonadsorbed compounds. The well plates were then filled with 200 p1 of diluted (2.000-fold) serum plus PBSTween containing BSA ( 5 g/L) and 10% glycerol. They were incubated at 37°C for 1 hr. Following this primary serum incubation, unbound antibodies were removed by two washings with PBS-Tween. Peroxidase-conjugated immunoglobulins (200 p1) were then added to the well plates. Horseradish peroxidase-conjugated goat immunoglobulins to human immunoglobulins (Diagnostic Pasteur, Marnes la Coquette, France) were diluted (20.000-fold) with PBS-Tween containing BSA (5 g/L). After this secondary antibodq incuhation ( 1 hr at 37°C). unbound antibodies were removed by two washer; with PBS-Tween. The substrate solution for peroxidase assay was 0.04 g/L of o-phenylenediamine (Sigma) in 0.1 M citrate-0.2 M sodium phosphate. pH 5. and 20 pl of hydrogen peroxide (Sigma) added just before use in 20 ml of substrate solution. It was added to each well and after incubating for I O min in the dark at room temperature, the reaction was stopped by the addition of 50 ~1 of 4 M H,SO,/ well. The ahsorbance in the well plates was measured at 492 nm with a Multiskan spectrophotometer (MR h l O: Dynatech Laboratories, Alexandria. VA). The specific immunologic binding of sera was obtained hy substracting blank values read on well plates coated with BSA-G (or BSA-AG) from experimental absorbance values. Four assays were performed for each serum sample and good reproducihility was obtained.
Statistical methods. Results are expressed as the mean -1-SEM except when otherwise stated. Comparison between group means was made using the nonparametric hlann-Whitney U test ( n < 30). A P Lalue less than 0.05 was considered significant.
RESULTS
Immunologic binding of sera from patients with human African trypanosomiasis using tryptophan glutaraldehyde or anhydric glutaric acid conjugates. Tryptophan was conjugated to BSA via either glutaraldehyde or anhydric glutaric acid. In the initial series of experiments, sera from African controls living in an endemic area ( n = 22). patients with stage I ( n = 24) sleeping sickness, and patients Lvith stage II (n = 16) sleeping sickness were examined. For these three groups, the mean 4 SEhl absorbance values reflecting anti-conjugated tryptophan-like epitope :intibodies were 0. Determination of immunoglobulin specificity by titration of sera from patients with human African trypanosomiasis. Serum titration was performed only on the glutaraldehyde tryptophan conjugate (W-G-BSA) with nine sera from patients with human African trypanosomiasis and sera from 16 controls (eight Africans living in France and eight Africans living in an endemic area). Two-fold serial dilutions from 1 X were performed. Each sera was assayed on tryptophan conjugate (W-G-BSA) and the mean 5 SEM optical density (OD) readings were then obtained for each sera group. At serum dilutions as high as 1/8,000, immunoreactivity was found only in trypanosomiasis sera (OD = 0.423 -I O.lZO), whereas no binding was found with control sera (Figure 1) .
Immunoglobulin levels in sera of controts and patients with human African trypanosomiasis. The amounts of IgG, IgA, and IgM in sera of patients with human African trypanosomiasis and controls were evaluated using a nephelometric procedure. Patients with human African trypanosomiasis showed increased levels of IgG (21-66.2 mg/ml) and IgM (0.96-3 1.2 mg/mI).
This was previously described in trypanosomiasis.20 No correlation between high antibody levels and IgM levels was found in sera of human African trypanosomiasis patients. The control group (Africans living to 64 X in an endemic area) also had high levels of IgG (15.2-27.8 mg/ml) and IgM (1.57-10.7 mg/ml), but they were usually lower than in patients. The Ig increase in controls may be associated with other infections.
Study of antibody recognition with indoleamine and catecholamine conjugates. To evaluate the best immunologic binding, we assayed sera in human African trypanosomiasis with six indoleamine and five catecholamine conjugates coupled to BSA via glutaraldehyde. They were coated on well plates and sera (diluted 1/2,000) from the four control groups and the patients with human African trypanosomiasis were classified according to the stage of disease and tested. High anti-conjugated tryptophan epitope antibody levels were found in the sera of patients with human African trypanosomiasis (Figure 2) . Means with 95% confidence intervals (in parentheses) were 0.702 (0.617-0.787) for African controls living in an endemic area, 1.107 (0.99-1.224) for patients with stage I disease, and 1.344 (1.166-1.522) for patients with stage II disease. These antibodies were of the M isotype. Concerning other conjugates, a low immunoreactivity was also observed for the tryptamine conjugate (T-G-BSA) but this binding was not statistically significant. Other tryptamine-like conjugates (HT [serotonin] [HT-G-SA] and MT [MT-G-BSA] ) were examined but their reactivities were very low.
Low reactivity was obtained for catecholamine conjugates. No statistical difference between sera from patients with human African trypanosomiasis and sera from controls was found. For example, the mean 5 SEM absorbance values for the dopamine conjugate @A-G-BSA) were 0.185 ? 0.102, 0.145 1 0.049, 0.170 1 0.056, and 0.296 k 0.114, respectively, for the African controls living in France (n = lo), the African controls living in an endemic area (n = lo), the patients with stage I disease (n = 9), and the patients with stage II disease (n = 8). Results obtained with other catecholamine conjugates were similar to those with DA-G-
BSA.
Only tryptophan-like conjugates were studied further. The best response was obtained with W-G-BSA, followed by MW-G-BSA and HW-G-BSA. Analysis of results showed a highly significant difference between mean OD values of controls and those of patients for two conjugates (W-G-BSA and MW-G-BSA). The immunoreactivity of sera from patients with human African trypanosomiasis was much stronger in stage II of the disease than in stage I of the disease, but the difference between the two was not significant. High levels of anti-conjugated tryptophan-like epitope antibodies was correlated with clinical neurologic symptoms: 8 1.18% of the patients with major neurologic signs or 75% of the patients with stage II disease had an OD value greater than the critical value (mean 3-2 SD = 1.087) calculated from reference group controls (Africans living in an endemic area) (Tables 1 and 2 ). Results also showed that African controls living in an endemic area had mean absorbance values higher than the other controls.
Evaluation of the specificity of this antibody binding according to different pathologic processes. To evaluate whether circulating antibodies were specific to human African trypanosomiasis, we sought the presence of such antibodies of the M isotype in sera from patients with HLV infection and Parkinson's disease. We found an increased (Figure 3 ) . These data unilerlined spccific it~~niunologic biniiing ilircc[cd against tryptuplian-like COIIjugatss in Iiuman Africiiii tryPanosoiniasis w~.
with human African trypanosomiasis. This immunologic hinding was related to the IgM isotype. We found reactivity of sera \vitIl the tryptophan glutaraldehyde conjugate (\\'-G-BSA), but not with corijugatcs made with glutaric anhydride acid (\Y-AG-BSA). This indicates the iinportance of the confor.m:ition of the hapten adsorbed o n the well plates after conjugate synthesis. The presence of a carboxyl terminal grnup in tryptophan conjugates is an impnrtant element for ;ìntibody recugnition hecause tryptamine conjugates, \vhich liuve an amino terminal group, are poorly rectignized ( Figure  2) .
Imrnuriologic binding to ~lutaraldehyJe-tr);ptophan conjugates n a s evaluated :tnd a line:lr decrense i n OD indicated the specificity of thc Ig from p:itients \villi human African t q Ixinosmiiasis (Figure 1 Tables 1 and 2 ).
The increase of circulating autoantibodies in patients with human African trypanosomiasis is probably dependent on polyclonal B cell activation, but it may reflect an additional specific stimulation by autoantigens or by cross-reacting antigens.6 High antibody titers against myelin basic protein, cerebrosides, and gangliosides have been found in murine experimental African trypanosomiasis."' Antibodies to myelin components (galactocerebrosides) have been found in sera of humans with African trypanosomiasis? Low titers of naturally occurring anti-galactocerebroside antibodies have been reported in the sera of healthy humans, compared with higher titers observed in patients with human African trypanosomiasis.4 These antibodies may contribute to the pathologic consequences observed. Also, experimental demyelinization has been induced by injection of antigalactocerebroside antibodies.22 Similar mechanisms have been proposed to explain the pathologic aspects of South American trypano~omiasis.~~ A comparison between immunologic binding in sera of patients with human African trypanosomiasis and other neurologic diseases shows a selec- tive increase of anti-conjugated tryptophan antibody levels only in the sera of patients with human African trypanosomiasis ( Figure 3 ) . Indoleamine compounds are largely distributed in the CNS.'4 Serotonin (HT) is a major neurotransmitter invohed in the control of numerous CNS functions. including aggressive and self-injurious behavior, regulation of sleep states and psychiatric disorders. including schizophrenia. and depression.25 Tryptophan is the natural amino acid precursor in HT biosynthesis. It has previously been stated that HW. the first metabolite deriving directly from tryptophan, could be considered to be a putative neurotransmitter that may play a role in the regulation of the sleep/wake cycle.2h ?' Moreover. some studies have indicated the presence of a specific binding of HW to membrane receptors.2h Thus. the multiplicity of HT receptors could be related to members of the indoleamine family. such as HW and tryptophan itself. In rat and human brains. the choroid plexus has larger amounts of HT-lihe receptors compared with other regions such as the pallidum or substantia nigra.?' Supra-ependymal nerve terminals derived from serotoninergic cells have their origin in the raphe nuclei.'" Serotonin nerve terminals are present on the walls of the ventricles and they could release HT into the CSE During sleeping sickness, ependyma cells and the supraependymal plexus are destroyed by parasites.lcl Antibodies directed against tryptophan-like conjugates could play a role in the pathophysiology of the disease or could merely be a sign of tissue degradation devoid of effects.
Their pathologic role in this disease, if any. will be clarified by further studies.
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